Vagal Nerve Stimulation Market 2019

Posted August 29, 2019 by nita01

The Global Vagal Nerve Stimulation Market Is Expected To Grow At A CAGR Of ~ 8.68 % During The Forecast Period 2017-2023.
August 29, 2019 — Market Highlights
The Global Vagal Nerve Stimulation Market Is Expected To Grow At A CAGR Of ~ 8.68 % During The Forecast Period 2017-2023.
Vagus nerve stimulation is a treatment for neurological disorders like epilepsy that involves a stimulator or pulse generator, which is placed inside the body and connected to the left vagus nerve in the neck. The stimulator sends regular, mild electrical stimulations through this nerve to help calm down the irregular electrical brain activity that leads to seizures. The treatment for epilepsy works differently from patient to patient and vagus nerve stimulation therapy is a form of treatment for people with epilepsy whose seizures are not controlled with medication. Implants like electronic neck implant are important for treating neurological disorder such as epilepsy.
According to Migraine Research Foundation, (2014), migraine was the 3rd most prevalent illness in the world. Nearly 1 in 4 U.S. households includes someone with migraine. Moreover, 12% of the population including children have migraine problem. 18% of American women, 6% of men, and 10% of children experience migraines. Mostly migraine occurs at the age of 25-55.
Increasing prevalence of neurological disorder like epilepsy, rising need for better treatment, increasing investment of biotechnology and pharmaceutical industries in R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapid development in technology will fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the review period.
Key Players
Some of key the players in the market are LivaNova PLC (UK), EnteroMedics Inc. (US), ElectroCore Medical LLC (US), Boston Scientific Corporation (US), Cyberonics, Inc. (US), NeuroMetrix, Inc.(US), ImThera Medical (US), and Inspire Medical Systems, Inc.(US).
The global vagal nerve stimulation market is segmented on the basis of products, application, and end user.
On the basis of products, the market is segmented into implantable VNS devices and external VNS devices.
On the basis of application, the market is segmented into depression, epilepsy, migraine, and others.
On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and others.
-- end ---
Contact Email [email protected]
Issued By marketreseasrchfuture
Phone 6468459312
Business Address Market Research Future
Office No. 528, Amanora Chambers
Country India
Categories Biotech , Health
Tags Vagal Nerve Stimulation Market , Vagal Nerve Stimulation Market size , Vagal Nerve Stimulation Market share
Last Updated August 29, 2019